Novartis has bulked up its cardiology pipeline with a $1.4 billion takeover of Tourmaline Bio and its phase 3-ready drug for atherosclerotic cardiovascular disease (ASCVD). The Swiss pharma group has ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Tourmaline Bio ( (TRML)) has provided an ...

The best shower filter can improve your skin, hair and nails by upgrading your home’s water quality. Go ahead, get your glow ...

Basel, October 28, 2025 - Novartis today announced that it has successfully completed its acquisition of Tourmaline Bio, Inc. (“Tourmaline”). With the completion of the acquisition, shares of common ...

Quite a few insiders have dramatically grown their holdings in Tourmaline Oil Corp. (TSE:TOU) over the past 12 months. An insider's optimism about the company's prospects is a positive sign. Although ...

Tourmaline has an expansion plan and expects to increase its production by 36.40% from 2024 to 2029. TOU:CA expects to pay CA$750 million over the next years in base dividends. At that level, ...

Novartis AG has completed its acquisition of Tourmaline Bio, Inc. (NASDAQ:TRML), according to a statement released Tuesday. The transaction was carried out through a merger agreement dated September 8 ...

Tourmaline Oil Corp. is an oil and natural gas company, which engages in the acquisition, exploration, development, and production of petroleum and natural gas properties. It focuses on its program in ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...